<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="8b5e0f3a-7f61-4ea2-a454-bf57d41e03ae"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use DEXTROSE INJECTION 20%, 30%, 40%, 50% and 70% safely and effectively. See full prescribing information for DEXTROSE INJECTION 20%, 30%, 40%, 50% and 70%.<br/>DEXTROSE injection, for intravenous use<br/>Initial U.S. Approval: 1940</title>
   <effectiveTime value="20200617"/>
   <setId root="b5cb7a5a-bbe8-4217-a82e-da818f7771c9"/>
   <versionNumber value="5"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="118380146" root="1.3.6.1.4.1.519.1"/>
            <name>ICU Medical Inc.</name>
            <assignedEntity>
               <assignedOrganization/>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section ID="DLDE">
               <id root="4b08aa95-06c8-43bc-91cb-065bee799ab9"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20200617"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0990-7918" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dextrose</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>dextrose</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="70" unit="g"/>
                              <denominator value="100" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="LX22YL083G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXTROSE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5SL0G7R0OK" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ANHYDROUS DEXTROSE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="500" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                                    <asContent>
                                       <quantity>
                                          <numerator value="12" unit="1"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="0990-7918-19" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43184" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CASE"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20191001"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA018561" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20191001"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0990-7935" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dextrose</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>dextrose</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="20" unit="g"/>
                              <denominator value="100" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="LX22YL083G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXTROSE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5SL0G7R0OK" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ANHYDROUS DEXTROSE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="500" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                                    <asContent>
                                       <quantity>
                                          <numerator value="12" unit="1"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="0990-7935-19" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43184" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CASE"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20191001"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA018564" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20191001"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0990-7936" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dextrose</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>dextrose</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="50" unit="g"/>
                              <denominator value="100" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="LX22YL083G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXTROSE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5SL0G7R0OK" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ANHYDROUS DEXTROSE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="500" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                                    <asContent>
                                       <quantity>
                                          <numerator value="12" unit="1"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="0990-7936-19" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43184" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CASE"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20191001"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA018563" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20191001"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0990-7937" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dextrose</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>dextrose</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="40" unit="g"/>
                              <denominator value="100" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="LX22YL083G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXTROSE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5SL0G7R0OK" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ANHYDROUS DEXTROSE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="500" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                                    <asContent>
                                       <quantity>
                                          <numerator value="12" unit="1"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="0990-7937-19" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43184" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CASE"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20191001"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA018562" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20191001"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0990-8004" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dextrose</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>dextrose</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="30" unit="g"/>
                              <denominator value="100" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="LX22YL083G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXTROSE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5SL0G7R0OK" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ANHYDROUS DEXTROSE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="500" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                                    <asContent>
                                       <quantity>
                                          <numerator value="12" unit="1"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="0990-8004-15" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43184" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CASE"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20191001"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA019345" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20191001"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_4664db92-f9aa-4007-84e9-972ceac41523">
               <id root="f2cbc1b2-e1ae-41ad-93e4-18554228ae47"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE </title>
               <text>
                  <paragraph>Dextrose Injection 20%, 30%, 40%, 50% and 70%, mixed with amino acids or other compatible intravenous fluids, is indicated as a source of calories for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.</paragraph>
               </text>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Dextrose Injection 20%, 30%, 40%, 50% and 70%, mixed with amino acids or other compatible intravenous fluids, is indicated as a source of calories for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient or contraindicated (<linkHtml href="#ID_4664db92-f9aa-4007-84e9-972ceac41523">1</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_95e80559-8355-4fde-8976-21517c16977d">
               <id root="70fb56a6-f7c4-4a1c-ae95-96dc0dcfa571"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION </title>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Must be diluted with compatible intravenous fluids or used as admixture, prior to administration. <content styleCode="bold">Not for direct intravenous infusion</content>. (<linkHtml href="#ID_b696c742-e199-43e3-a638-e3a0abde5b21">2.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Only for slow intravenous infusion only into a: (<linkHtml href="#ID_b696c742-e199-43e3-a638-e3a0abde5b21">2.1</linkHtml>)<list listType="unordered">
                                 <item>
                                    <caption>o</caption>
                                    <content styleCode="underline">Central vein</content>, if final dextrose concentration is greater than 5% or osmolality is greater than 900 mOsm/L</item>
                                 <item>
                                    <caption>o</caption>
                                    <content styleCode="underline">Peripheral vein</content>, if final dextrose concentration 5% or less and osmolality is less than 900 mOsm/L</item>
                              </list>
                           </item>
                           <item>
                              <caption>•</caption>Individualize dosage based on the patient's clinical condition, body weight, nutritional/fluid requirements, as well as additional energy given orally/enterally (<linkHtml href="#ID_905c72c3-3b0a-48bf-8724-9aa32be31a9d">2.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Discontinue infusion of concentrated dextrose solutions slowly and/or administer 5% dextrose (<linkHtml href="#ID_85f9de9d-21a7-45b5-80b4-2955b8ad726d">2.3</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_b696c742-e199-43e3-a638-e3a0abde5b21">
                     <id root="8e63e8b1-115d-4068-915a-250720b0f229"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1	Important Preparation and Administration Instructions </title>
                     <text>
                        <paragraph>Dextrose Injection is supplied in the following five strengths: 20%, 30%, 40%, 50% and 70% <content styleCode="italics">[see How Supplied/Storage and Handling (<linkHtml href="#ID_fd5fef4a-b120-4f1b-a3a1-e0848d1cb3e4">16</linkHtml>)]</content>
                           <content styleCode="italics">.</content> Prior to administration, Dextrose Injection <content styleCode="italics">must be diluted</content> with other compatible intravenous fluids or <content styleCode="italics">used as an admixture</content> with amino acids. <content styleCode="italics">It is not for direct intravenous infusion</content>.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Preparation Prior to Administration</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Because additives may be incompatible, evaluate all additions to the plastic container for compatibility and stability of the resulting preparation. Consult with a pharmacist, if available. If it is deemed advisable to introduce additives, use aseptic technique and mix thoroughly.</item>
                           <item>
                              <caption>•</caption>Inspect Dextrose Injection to ensure precipitates have not formed during the mixing or addition of additives. Discard the bag if precipitates are observed. Some opacity of the plastic container (due to moisture absorption during sterilization process) may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.</item>
                           <item>
                              <caption>•</caption>Use promptly after admixing or dilution.</item>
                           <item>
                              <caption>•</caption>For single use only; discard unused portion</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">Important Administration Instructions</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Set the vent to the closed position on a vented intravenous administration set to prevent air embolism.</item>
                           <item>
                              <caption>•</caption>Use a dedicated line without any connections to avoid air embolism.</item>
                           <item>
                              <caption>•</caption>Prior to infusion, visually inspect the diluted dextrose solution for particulate matter. The solution should be clear and there should be no precipitates. Do not administer unless solution is clear and container is undamaged.</item>
                           <item>
                              <caption>•</caption>The choice of a central or peripheral venous route of infusion should depend on the osmolarity of the final infusate. Solutions with greater than 5% dextrose or with osmolarity of greater than or equal to 900 mOsm/L must be infused through a central catheter <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_7fda8414-2ba2-4366-9c2a-6628c85c0994">5.5</linkHtml>)]</content>.</item>
                        </list>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_905c72c3-3b0a-48bf-8724-9aa32be31a9d">
                     <id root="a1e34503-5f86-48f8-9e27-49756a9cca9c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2	Dosing Information </title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Caution: Dextrose Injection is not for direct intravenous infusion. </content>Prior to administration, Dextrose Injection <content styleCode="italics">must be diluted</content> with other compatible intravenous fluids or <content styleCode="italics">used as an admixture</content> with amino acids.</paragraph>
                        <paragraph>Individualize the dosage of Dextrose Injection based on the patient's clinical condition (ability to adequately metabolize dextrose), body weight, nutritional and fluid requirements, as well as additional energy given orally or enterally to the patient.</paragraph>
                        <paragraph>The administration rate should be governed, especially during the first few day of therapy, by the patient's tolerance to dextrose. Daily intake of amino acids and dextrose should be increased gradually to the maximum required dose as indicated by frequent determinations of blood glucose levels.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_85f9de9d-21a7-45b5-80b4-2955b8ad726d">
                     <id root="bfa68674-7a64-4a0a-9c95-913900af726c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.3	Discontinuation of Dextrose Injection </title>
                     <text>
                        <paragraph>To reduce the risk of hypoglycemia, a gradual decrease in flow rate in the last hour of infusion should be considered.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_1e604695-bc7c-4672-92dc-14af6de1eba4">
               <id root="34976c0d-7c11-4b42-950b-94e5989ad2b4"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS </title>
               <text>
                  <paragraph>Dextrose Injection 20%, 30%, 40%, 50%, and 70% USP are sterile, non-pyrogenic, hypertonic solutions of dextrose in single-dose, partial-fill, flexible containers.</paragraph>
                  <paragraph>
                     <content styleCode="underline">500 mL fill volume in 1000 mL flexible container</content>
                  </paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>20% (0.2 grams/mL): 20 grams of dextrose hydrous per 100 mL</item>
                     <item>
                        <caption>•</caption>30% (0.3 grams/mL): 30 grams of dextrose hydrous per 100 mL</item>
                     <item>
                        <caption>•</caption>40% (0.4 grams/mL): 40 grams of dextrose hydrous per 100 mL</item>
                     <item>
                        <caption>•</caption>50% (0.5 grams/mL): 50 grams of dextrose hydrous per 100 mL</item>
                     <item>
                        <caption>•</caption>70% (0.7 grams/mL): 70 grams of dextrose hydrous per 100 mL</item>
                  </list>
               </text>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Injection: Single-dose, partial-fill, flexible containers with (<linkHtml href="#ID_1e604695-bc7c-4672-92dc-14af6de1eba4">3</linkHtml>):</paragraph>
                        <paragraph>
                           <content styleCode="underline">500 mL fill volume in 1000 mL flexible container:</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>20% (0.2 grams/mL): 20 grams of dextrose hydrous per 100 mL</item>
                           <item>
                              <caption>•</caption>30% (0.3 grams/mL): 30 grams of dextrose hydrous per 100 mL</item>
                           <item>
                              <caption>•</caption>40% (0.4 grams/mL): 40 grams of dextrose hydrous per 100 mL</item>
                           <item>
                              <caption>•</caption>50% (0.5 grams/mL): 50 grams of dextrose hydrous per 100 mL</item>
                           <item>
                              <caption>•</caption>70% (0.7 grams/mL): 70 grams of dextrose hydrous per 100 mL</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_190a7f9e-6603-4754-ae0b-8f35a7fb8b92">
               <id root="b7eb5c31-414b-4f8b-a555-c0aea0a3377c"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS </title>
               <text>
                  <paragraph>The use of Dextrose Injection is contraindicated in patients:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>who are severely dehydrated as hypertonic dextrose solution can worsen the patient's hyperosmolar state.</item>
                     <item>
                        <caption>•</caption>with known hypersensitivity to dextrose <content styleCode="italics">[see <linkHtml href="#ID_103a987f-0cf3-4dff-9331-9a4d43cf765e">Warnings and Precautions (5.2)</linkHtml>]</content>.</item>
                  </list>
               </text>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>Severe dehydration (<linkHtml href="#ID_190a7f9e-6603-4754-ae0b-8f35a7fb8b92">4</linkHtml>)</item>
                           <item>
                              <caption>•</caption>Known hypersensitivity to dextrose (<linkHtml href="#ID_190a7f9e-6603-4754-ae0b-8f35a7fb8b92">4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_56e2ba86-4ffa-430a-82af-ff13833ad022">
               <id root="1235cd86-672c-4cf3-a1fd-6fc851b32ac8"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS </title>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Hyperglycemia or Hyperosmolar Hyperglycemic State</content>: Monitor blood glucose and administer insulin as needed (<linkHtml href="#ID_6555192f-53f4-4213-81f4-5a6cb2fa64cb">5.1</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Hypersensitivity Reactions</content>: Monitor for signs and symptoms and discontinue infusion if reactions occur (<linkHtml href="#ID_103a987f-0cf3-4dff-9331-9a4d43cf765e">5.2</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Risk of Infection</content>: Monitor for signs and symptoms and laboratory parameters (<linkHtml href="#ID_b50e81a6-3ccf-4d57-b89d-307df39e893c">5.3</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Refeeding Syndrome</content>: Monitory laboratory parameters (<linkHtml href="#ID_342d11b7-db74-4f09-b352-c345d709e564">5.4</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Vein Damage and Thrombosis</content>: Administer solutions containing more than 5% dextrose as the final concentration or solutions with an osmolarity ≥ 900 mOsm/L through a central vein (<linkHtml href="#ID_b696c742-e199-43e3-a638-e3a0abde5b21">2.1</linkHtml>, <linkHtml href="#ID_7fda8414-2ba2-4366-9c2a-6628c85c0994">5.5</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Aluminum Toxicity</content>: Dextrose Injection contains aluminum that may be toxic. Patients with impaired renal function, and preterm infants, at higher risk. Limit aluminum to less than 4 mcg/kg/day (<linkHtml href="#ID_67a31497-24c6-4eb0-aa59-8bda9689650c">5.6</linkHtml>, <linkHtml href="#ID_87bdd552-088d-4fac-8e1b-f95b69e6aa94">8.4</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Parenteral Nutrition Associated Liver Disease</content>: increased risk in patients who receive parenteral nutrition for extended periods of time, especially preterm infants; monitor liver function tests, if abnormalities occur consider discontinuation or dosage reduction. (<linkHtml href="#ID_37040612-dd8f-4324-9888-f4e1906246a0">5.7</linkHtml>, <linkHtml href="#ID_87bdd552-088d-4fac-8e1b-f95b69e6aa94">8.4</linkHtml>)</item>
                           <item>
                              <caption>•</caption>
                              <content styleCode="underline">Electrolyte Imbalance and Fluid Overload</content>: monitor daily fluid balance, blood electrolyte levels, correct as needed. (<linkHtml href="#ID_9b49162c-1f26-47a4-a9ce-43c19cab6cbf">5.8</linkHtml>, <linkHtml href="#ID_87bdd552-088d-4fac-8e1b-f95b69e6aa94">8.4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_6555192f-53f4-4213-81f4-5a6cb2fa64cb">
                     <id root="3ffb7122-2566-49ba-bad0-e234555b5ac0"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1	Hyperglycemia and Hyperosmolar Hyperglycemic State </title>
                     <text>
                        <paragraph>The use of dextrose infusions in patients with diabetes mellitus or impaired glucose tolerance may worsen hyperglycemia. Administration of dextrose at a rate exceeding the patient's utilization rate may lead to hyperglycemia, coma, and death. Patients with underlying confusion and renal impairment who receive dextrose infusions, may be at greater risk of developing hyperosmolar hyperglycemic state. Monitor blood glucose levels and treat hyperglycemia to maintain optimum levels while administering Dextrose Injection. Insulin may be administered or adjusted to maintain optimal blood glucose levels during Dextrose Injection administration.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_103a987f-0cf3-4dff-9331-9a4d43cf765e">
                     <id root="9ed0b1dd-c007-4256-b273-fb4e9a51a548"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2	Hypersensitivity Reactions </title>
                     <text>
                        <paragraph>Hypersensitivity reactions including anaphylaxis have been reported with dextrose infusions. Stop infusion immediately and treat patient accordingly if signs or symptoms of a hypersensitivity reaction develop. Signs or symptoms may include: tachypnea, dyspnea, hypoxia, bronchospasm, tachycardia, hypotension, cyanosis, vomiting, nausea, headache, sweating, dizziness, altered mentation, flushing, rash, urticaria, erythema, pyrexia, and chills.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_b50e81a6-3ccf-4d57-b89d-307df39e893c">
                     <id root="0cfb5c58-6ee5-4c7f-9087-7340038e85f0"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3	Risk of Infections </title>
                     <text>
                        <paragraph>Patients who require parenteral nutrition are at high risk of infections because the nutritional components of these solutions can support microbial growth. The risk of infection is increased in patients with malnutrition-associated immunosuppression, hyperglycemia exacerbated by dextrose infusion, long-term use and poor maintenance of intravenous catheters, or immunosuppressive effects of other concomitant conditions, drugs, or other components of the parenteral formulation (e.g., lipid emulsion).</paragraph>
                        <paragraph>To decrease the risk of infectious complications, ensure aseptic technique in catheter placement and maintenance, as well as aseptic technique in the preparation and administration of the nutritional formula.</paragraph>
                        <paragraph>Monitor for signs and symptoms (including fever and chills) of early infections, including laboratory test results (including leukocytosis and hyperglycemia) and frequent checks of the parenteral access device and insertion site for edema, redness and discharge.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_342d11b7-db74-4f09-b352-c345d709e564">
                     <id root="6f7aa09c-6836-4514-8c9e-7e48bb56f96e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4	Refeeding Syndrome </title>
                     <text>
                        <paragraph>Refeeding severely undernourished patients may result in refeeding syndrome, characterized by the intracellular shift of potassium, phosphorus, and magnesium as the patient becomes anabolic. Thiamine deficiency and fluid retention may also develop. To prevent these complications, monitor severely undernourished patients and slowly increase nutrient intakes.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_7fda8414-2ba2-4366-9c2a-6628c85c0994">
                     <id root="3c6611c8-8ed2-4778-845a-e9ff679659ae"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5	Vein Damage and Thrombosis </title>
                     <text>
                        <paragraph>Dextrose Injection is for admixture with amino acids or dilution with other compatible intravenous fluids. It is not for direct intravenous infusion. Administer solutions containing more than 5% dextrose or with an osmolarity of ≥ 900 mOsm/L through a central vein <content styleCode="italics">[see Dosage and Administration (<linkHtml href="#ID_b696c742-e199-43e3-a638-e3a0abde5b21">2.1</linkHtml>)]</content>. The infusion of hypertonic solutions into a peripheral vein may result in vein irritation, vein damage, and/or thrombosis. The primary complication of peripheral access is venous thrombophlebitis, which manifests as pain, erythema, tenderness or a palpable cord. Remove the catheter as soon as possible, if thrombophlebitis develops.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_67a31497-24c6-4eb0-aa59-8bda9689650c">
                     <id root="9a3c11ba-7d54-4cbe-aba9-ff8a944c55dd"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.6	Aluminum Toxicity </title>
                     <text>
                        <paragraph>Dextrose Injection contains no more than 25 mcg/L of aluminum. However, with prolonged parenteral administration in patients with renal impairment, the aluminum contained in Dextrose Injection may reach toxic levels. Preterm infants are at greater risk because their kidneys are immature, and they require large amounts of concomitant calcium and phosphate solutions that contain aluminum. Patients with renal impairment, including preterm infants, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day, accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration of total parenteral nutrition products.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_37040612-dd8f-4324-9888-f4e1906246a0">
                     <id root="4fbd1d6b-2df6-4d7c-8f1d-a9ac793b0832"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.7	Risk of Parenteral Nutrition Associated Liver Disease </title>
                     <text>
                        <paragraph>Parenteral Nutrition Associated Liver Disease (PNALD) has been reported in patients who receive parenteral nutrition for extended periods of time, especially preterm infants, and can present as cholestasis or steatohepatitis. The exact etiology is not entirely clear and is likely multifactorial. If Dextrose Injection-treated patients develop abnormal liver function tests consider discontinuation or dosage reduction.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_9b49162c-1f26-47a4-a9ce-43c19cab6cbf">
                     <id root="a597065f-e16a-4350-a226-fef78bd66f0a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.8	Electrolyte Imbalance and Fluid Overload  </title>
                     <text>
                        <paragraph>Electrolyte deficits, particularly in serum potassium and phosphate, may occur during prolonged use of concentrated dextrose solutions.</paragraph>
                        <paragraph>Depending on the volume and rate of infusion, the intravenous administration of concentrated dextrose solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations in the administered solution. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations in the solution. </paragraph>
                        <paragraph>Monitor blood electrolyte levels, correct fluid and electrolyte imbalances, and administer essential vitamins and minerals as needed. Monitor daily fluid balance.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_2fdbf30e-e89f-4a61-8129-7acb3f935fd8">
               <id root="437d328e-a6b4-42da-b5e8-fcff90fd672f"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS </title>
               <text>
                  <paragraph>The following adverse reactions from voluntary reports or clinical studies have been reported with Dextrose Injection. Because many of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>Hyperglycemia and hyperosmolar hyperglycemic state <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_6555192f-53f4-4213-81f4-5a6cb2fa64cb">5.1</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Hypersensitivity reactions <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_103a987f-0cf3-4dff-9331-9a4d43cf765e">5.2</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Risk of infections <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_b50e81a6-3ccf-4d57-b89d-307df39e893c">5.3</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Refeeding syndrome <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_342d11b7-db74-4f09-b352-c345d709e564">5.4</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Vein damage and thrombosis <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_7fda8414-2ba2-4366-9c2a-6628c85c0994">5.5</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Aluminum toxicity <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_67a31497-24c6-4eb0-aa59-8bda9689650c">5.6</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Risk of parenteral nutrition associated liver disease <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_37040612-dd8f-4324-9888-f4e1906246a0">5.7</linkHtml>)]</content>.</item>
                     <item>
                        <caption>•</caption>Electrolyte imbalance and fluid overload <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_9b49162c-1f26-47a4-a9ce-43c19cab6cbf">5.8</linkHtml>)]</content>.</item>
                  </list>
               </text>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>The most common adverse reactions are hyperosmolar syndrome, infection both systemic and at the injection site, vein thrombosis or phlebitis, and hypervolemia. (<linkHtml href="#ID_2fdbf30e-e89f-4a61-8129-7acb3f935fd8">6</linkHtml>)</paragraph>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact ICU Medical, Inc. at 1-800-441-4100, or FDA at 1-800-FDA-1088 or <content styleCode="italics">
                                 <linkHtml href="http://www.fda.gov/Safety/MedWatch/default.htm">www.fda.gov/medwatch</linkHtml>
                              </content>.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_d2e1551d-4ccc-46ce-82a5-22eee106f522">
               <id root="45334676-345c-49ae-a8af-16348190a553"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS </title>
               <effectiveTime value="20181130"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Pediatric Use:</content> Increased risk of hypoglycemia/hyperglycemia; monitor serum glucose concentrations. (<linkHtml href="#ID_87bdd552-088d-4fac-8e1b-f95b69e6aa94">8.4</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_fe545164-84a3-42ac-b77d-8933e56ca112">
                     <id root="375f7e70-57eb-40a6-8dab-f2c8befdaac8"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>There are no data with Dextrose Injection in pregnant women. In addition, animal reproduction studies have not been conducted with dextrose. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Clinical Considerations</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Disease-Associated Maternal and/or Embryo/Fetal Risk</content>
                        </paragraph>
                        <paragraph>Consider parenteral nutrition in cases of severe maternal malnutrition where nutritional requirements cannot be fulfilled by the enteral route because of the risks to the fetus associated with severe malnutrition, including preterm delivery, low birth weight, intrauterine growth restriction, congenital malformations, and perinatal mortality.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_fe0aa5bd-4874-4100-99e7-3ab9768f84ec">
                     <id root="c066c525-176c-473c-b60e-754e6678fbc6"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation </title>
                     <text>
                        <paragraph>There are no data regarding the presence of dextrose in human milk, the effects on a breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Dextrose Injection and any potential adverse effects on the breastfed infant from Dextrose Injection or from the underlying maternal condition.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_87bdd552-088d-4fac-8e1b-f95b69e6aa94">
                     <id root="673adacf-0895-42c0-8e4e-24fe857599fc"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use </title>
                     <text>
                        <paragraph>Neonates, especially those born premature and with low birth weight are at increased risk of developing hypo – or hyperglycemia and therefore need close monitoring during treatment with intravenous glucose infusions to ensure adequate glycemic control in order to avoid potential long term adverse effects. Hypoglycemia in the newborn can cause prolonged seizures, coma and brain damage. Hyperglycemia has been associated with intraventricular hemorrhage, late onset bacterial and fungal infection, retinopathy of prematurity, necrotizing enterocolitis, bronchopulmonary dysplasia, prolonged length of hospital stay, and death. Plasma electrolyte concentrations should be closely monitored in the pediatric population as this population may have impaired ability to regulate fluids and electrolytes. In very low birth weight infants, excessive or rapid administration of Dextrose Injection may result in increased serum osmolality and possible intracerebral hemorrhage.</paragraph>
                        <paragraph>Because of immature renal function, preterm infants receiving prolonged treatment with Dextrose Injection, may be at risk aluminum toxicity <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_67a31497-24c6-4eb0-aa59-8bda9689650c">5.6</linkHtml>)]</content>.</paragraph>
                        <paragraph>Patients, including pediatric patients, may be at risk for Parenteral Nutrition Associated Liver Disease (PNALD) <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_37040612-dd8f-4324-9888-f4e1906246a0">5.7</linkHtml>)]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_494f265c-8284-4e5e-b192-da2d8bcffb6f">
                     <id root="4ebbe8f5-a960-4b62-b7a9-45a3e7fff155"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use </title>
                     <text>
                        <paragraph>Clinical studies of Dextrose Injection did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from other younger patients. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_ffcfb35f-b828-4567-926d-679f5246b160">
               <id root="79c60e3f-47b1-4e57-a13b-8c0393af25a0"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE </title>
               <text>
                  <paragraph>An increased infusion rate of Dextrose Injection or administration of a concentrated dextrose solution can cause hyperglycemia, hyperosmolality, and adverse effects on water and electrolyte balance <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_6555192f-53f4-4213-81f4-5a6cb2fa64cb">5.1</linkHtml>, <linkHtml href="#ID_9b49162c-1f26-47a4-a9ce-43c19cab6cbf">5.8</linkHtml>)]</content>.</paragraph>
                  <paragraph>Severe hyperglycemia and severe dilutional hyponatremia, and their complications, can be fatal.</paragraph>
                  <paragraph>Discontinue infusion and institute appropriate corrective measures in the event of overhydration or solute overload during therapy, with particular attention to respiratory and cardiovascular systems<content styleCode="italics">.</content>
                  </paragraph>
                  <paragraph>For current information on the management of poisoning or overdosage, contact the National Poison Control Center at 1-800-222-1222 or <content styleCode="underline">
                        <linkHtml href="http://www.poison.org/">www.poison.org</linkHtml>
                     </content>.</paragraph>
               </text>
               <effectiveTime value="20181130"/>
            </section>
         </component>
         <component>
            <section ID="ID_8d19fff4-3433-4692-aad1-aae7c8534dca">
               <id root="6593bda3-ceee-4215-afa5-84ac1f3008b7"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION </title>
               <text>
                  <paragraph>Dextrose Injection, USP 20%, 30%, 40%, 50% and 70% are sterile, nonpyrogenic, hypertonic solutions of Dextrose, USP in Water for Injection in a polyvinylchloride flexible plastic container for intravenous administration after appropriate admixture or dilution <content styleCode="italics">[see Dosage and Administration (<linkHtml href="#ID_b696c742-e199-43e3-a638-e3a0abde5b21">2.1</linkHtml>)]</content>.</paragraph>
                  <paragraph>Partial-fill containers, designed to facilitate admixture or dilution to provide dextrose in various concentrations, are available in various sizes. See <linkHtml href="#_Reft1">Table 1</linkHtml> for the content and characteristics of these concentrated solutions<content styleCode="italics">. </content>The solutions contain no bacteriostatic, antimicrobial agent or added buffer and are intended only for use as a single-dose injection following admixture or dilution. The pH is 4.3 (range is 3.2 to 6.5).</paragraph>
                  <paragraph>Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly.</paragraph>
                  <table ID="_Reft1" width="100%">
                     <caption>Table 1. Contents and Characteristics of Dextrose Injection 20%, 30%, 40%, 50%, and 70%</caption>
                     <col width="30%"/>
                     <col width="18%"/>
                     <col width="26%"/>
                     <col width="14%"/>
                     <col width="12%"/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Strength</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Fill Volume</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">Amount of Dextrose Hydrous per Container</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">kcal</content>
                                 <footnote ID="_Ref439159195">Caloric value calculated on the basis of 3.4 kcal/g of dextrose, hydrous.</footnote>
                                 <br/>
                                 <content styleCode="bold">per Container</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Botrule Lrule Toprule " valign="middle">
                              <paragraph>
                                 <content styleCode="bold">mOsmol </content>
                                 <br/>
                                 <content styleCode="bold">per liter</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="middle">
                              <paragraph>20% (0.2 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>100 grams</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>340</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="middle">
                              <paragraph>1009</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="middle">
                              <paragraph>30% (0.3 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>150 grams</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>510</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="middle">
                              <paragraph>1514</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="middle">
                              <paragraph>40% (0.4 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>200 grams</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>680</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="middle">
                              <paragraph>2018</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="middle">
                              <paragraph>50% (0.5 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>250 grams</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                              <paragraph>850</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="middle">
                              <paragraph>2523</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="middle">
                              <paragraph>70% (0.7 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule " valign="middle">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule " valign="middle">
                              <paragraph>350 grams</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule " valign="middle">
                              <paragraph>1190</paragraph>
                           </td>
                           <td align="center" styleCode="Botrule Lrule " valign="middle">
                              <paragraph>3532</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>Dextrose, USP is chemically designated D-glucose, monohydrate (C<sub>6</sub>H<sub>12</sub>O<sub>6</sub> • H<sub>2</sub>O), a hexose sugar freely soluble in water. The molecular weight of dextrose (D-glucose) monohydrate is 198.17. It has the following structural formula:</paragraph>
                  <renderMultiMedia ID="id2130273615" referencedObject="F4C6383D-00DD-4323-A306-856DCF46F8C2"/>
                  <paragraph>Dextrose may be derived from corn.</paragraph>
                  <paragraph>Water for Injection, USP is chemically designated H<sub>2</sub>O.</paragraph>
                  <paragraph>Dextrose Injection contains no more than 25 mcg/L of aluminum.</paragraph>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="F4C6383D-00DD-4323-A306-856DCF46F8C2">
                     <text>Structural Formula for Dextrose Injection, USP</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="dextrose-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_85f8b4e4-9a96-4076-8916-dec4a4d67299">
               <id root="3ead918b-bab7-4209-bd71-1e8c9e6d4ed0"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY </title>
               <effectiveTime value="20181130"/>
               <component>
                  <section ID="ID_14f86dc6-3f83-44ca-82a1-57e9508f7ef0">
                     <id root="3fd94ee3-ea72-4f35-a68a-5f4dfa3510b5"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action </title>
                     <text>
                        <paragraph>Dextrose Injection is used to supplement nutrition by providing glucose parenterally. Dextrose is oxidized to carbon dioxide and water, yielding energy.</paragraph>
                     </text>
                     <effectiveTime value="20181130"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_fd5fef4a-b120-4f1b-a3a1-e0848d1cb3e4">
               <id root="8f53665b-b2c1-4cb4-8c0c-69b71e765965"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING </title>
               <text>
                  <paragraph>Dextrose Injection, 20%, 30%, 40%, 50%, and 70% USP are sterile hypertonic solutions of dextrose supplied in single-dose, partial-fill flexible containers (see <linkHtml href="#_Reft1">Tables 1</linkHtml> and <linkHtml href="#_Reft2">2</linkHtml>) for intravenous administration after appropriate admixture or dilution <content styleCode="italics">[see Dosage and Administration (<linkHtml href="#ID_b696c742-e199-43e3-a638-e3a0abde5b21">2.1</linkHtml>)]</content>.</paragraph>
                  <paragraph>Do not remove container from the overwrap until intended for use.</paragraph>
                  <table ID="_Reft2" width="100%">
                     <caption>Table 2: Strengths, Fill Volume, and NDC # of Dextrose Injection 20%, 30%, 40%, 50%, and 70%</caption>
                     <col width="35%"/>
                     <col width="35%"/>
                     <col width="29%"/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Strength</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Fill Volume</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">NDC#</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="top">
                              <paragraph>20% (0.2 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="top">
                              <paragraph>0409-7935-19<br/>0990-7935-19</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="top">
                              <paragraph>30% (0.3 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="top">
                              <paragraph>0409-8004-15<br/>0990-8004-15</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="top">
                              <paragraph>40% (0.4 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="top">
                              <paragraph>0409-7937-19<br/>0990-7937-19</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="top">
                              <paragraph>50% (0.5 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Lrule Botrule " valign="top">
                              <paragraph>0409-7936-19<br/>0990-7936-19</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule " valign="top">
                              <paragraph>70% (0.7 grams/mL)</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Botrule Lrule " valign="top">
                              <paragraph>500 mL</paragraph>
                           </td>
                           <td align="center" styleCode="Botrule Lrule " valign="top">
                              <paragraph>0409-7918-19<br/>0990-7918-19</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time. </paragraph>
                  <paragraph>Use the product immediately after mixing and the introduction of additives.</paragraph>
                  <paragraph>Store between 20°C to 25°C (68°F to 77°F). [See USP controlled room temperature.]</paragraph>
                  <paragraph>Do not freeze.</paragraph>
               </text>
               <effectiveTime value="20181130"/>
            </section>
         </component>
         <component>
            <section ID="ID_97e40086-4984-4f30-ac7e-0a0e1529015e">
               <id root="5a0ad928-a55d-41d6-8e1f-ee10617748dc"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION </title>
               <text>
                  <paragraph>Inform patients, caregivers, or home healthcare providers of the following risks of Dextrose Injection:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>Hyperglycemia and hyperosmolar hyperglycemic state <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_6555192f-53f4-4213-81f4-5a6cb2fa64cb">5.1</linkHtml>)]</content>
                     </item>
                     <item>
                        <caption>•</caption>Hypersensitivity reactions <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_103a987f-0cf3-4dff-9331-9a4d43cf765e">5.2</linkHtml>)]</content>
                     </item>
                     <item>
                        <caption>•</caption>Risk of infection <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_b50e81a6-3ccf-4d57-b89d-307df39e893c">5.3</linkHtml>)]</content>
                     </item>
                     <item>
                        <caption>•</caption>Vein damage and thrombosis <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_7fda8414-2ba2-4366-9c2a-6628c85c0994">5.5</linkHtml>)]</content>
                     </item>
                     <item>
                        <caption>•</caption>Aluminum toxicity <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_67a31497-24c6-4eb0-aa59-8bda9689650c">5.6</linkHtml>)]</content>
                     </item>
                     <item>
                        <caption>•</caption>Risk of parenteral nutrition associated liver disease <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_37040612-dd8f-4324-9888-f4e1906246a0">5.7</linkHtml>)]</content>
                     </item>
                     <item>
                        <caption>•</caption>Fluid overload and electrolyte imbalance <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#ID_9b49162c-1f26-47a4-a9ce-43c19cab6cbf">5.8</linkHtml>)]</content>
                        <br/>
                        <br/>
                        <br/>
                        <br/>
                     </item>
                  </list>
                  <paragraph>                                                                                EN-4695</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
               </text>
               <effectiveTime value="20181130"/>
            </section>
         </component>
         <component>
            <section>
               <id root="1eaf2820-3c81-42f0-a176-5f4e3c1a2059"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 70 g/100 mL Bag Label</title>
               <text>
                  <paragraph>500 mL<br/>NDC 0990-7918-19</paragraph>
                  <paragraph>
                     <content styleCode="bold">DEXTROSE<br/>INJECTION,<br/>USP</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">70%</content>
                  </paragraph>
                  <paragraph>IN 1000 mL PARTIAL-FILL CONTAINER<br/>EACH 100 mL CONTAINS DEXTROSE, HYDROUS, USP<br/>70 g IN WATER FOR INJECTION.<br/>HYPERTONIC OSMOLARITY 3532 mOsmol/LITER (calc).<br/>pH 4.3 (3.2 to 6.5)<br/>SPECIFIC GRAVITY 1.236<br/>
                     <content styleCode="bold">CAUTION: HYPERTONIC. ADMINISTER ONLY AFTER<br/>DILUTION VIA CENTRAL VENOUS CATHETER.</content>
                     <br/>STERILE, NONPYROGENIC. SINGLE DOSE CONTAINER.<br/>
                     <content styleCode="bold">DOSAGE AND ADMINISTRATION:</content> SEE PACKAGE<br/>INSERT.<br/>CAUTION: DO NOT USE UNLESS SOLUTION IS CLEAR,<br/>CLOSURE IS INTACT, AND CONTAINER IS<br/>UNDAMAGED. CHECK FOR MINUTE LEAKS BY<br/>SQUEEZING FIRMLY. IF LEAKS ARE FOUND DISCARD<br/>CONTAINER AND CONTENTS AS STERILITY MAY BE<br/>IMPAIRED. MUST NOT BE USED IN SERIES<br/>CONNECTIONS.</paragraph>
                  <paragraph>ADDITIVES MAY BE INCOMPATIBLE. CONSULT<br/>WITH PHARMACIST, IF AVAILABLE. WHEN<br/>INTRODUCING ADDITIVES, USE ASEPTIC<br/>TECHNIQUE, MIX THOROUGHLY AND DO NOT<br/>STORE.</paragraph>
                  <paragraph>
                     <content styleCode="bold">RECOMMENDED STORAGE:</content> ROOM TEMPERATURE<br/>(25°C/77°F). AVOID EXCESSIVE HEAT. PROTECT FROM<br/>FREEZING.<br/>Rx ONLY</paragraph>
                  <paragraph>IM-4402</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">3<br/>v</content>
                     <br/>CONTAINS DEHP 						</paragraph>
                  <paragraph>
                     <content styleCode="bold">70%</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM3"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM3">
                     <text>PPRINCIPAL DISPLAY PANEL - 70 g/100 mL Bag Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="4f3a7e51-a726-45bc-b624-ae0af76a6fd9"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 70 g/100 mL Bag Overwrap</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">TO OPEN — TEAR AT NOTCH</content>
                  </paragraph>
                  <paragraph>The overwrap is a moisture and oxygen barrier. Do not remove<br/>unit from overwrap until ready for use. Visually inspect<br/>overwrap for tears or holes. Discard unit if overwrap is<br/>damaged. Use unit promptly when pouch is opened. Store at<br/>20 to 25°C (68 to 77°F). [See USP Controlled Room<br/>Temperature.] Protect from freezing. See insert. After<br/>removing the overwrap, check for minute leaks by squeezing<br/>container firmly. If leaks are found, discard solution as sterility<br/>may be impaired.</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>WR-0551</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM4"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM4">
                     <text>PRINCIPAL DISPLAY PANEL - 70 g/100 mL Bag Overwrap</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-04.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="f811ff42-c2fe-4fae-8630-258aa6dc0a23"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 20 g/100 mL Bag Label</title>
               <text>
                  <paragraph>500 mL<br/>IN 1000 mL PARTIAL-FILL CONTAINER</paragraph>
                  <paragraph>NDC 0990-7935-19</paragraph>
                  <paragraph>
                     <content styleCode="bold">20% DEXTROSE</content>
                     <br/>Injection, USP</paragraph>
                  <paragraph>EACH 100 mL CONTAINS DEXTROSE,<br/> HYDROUS 20 g IN WATER FOR INJECTION.<br/>1009 mOsmol/LITER (CALC.)<br/>pH 4.3 (3.2 to 6.5)<br/>
                     <content styleCode="bold">CAUTION: HYPERTONIC. ADMINISTER<br/> ONLY AFTER DILUTION.</content> DEXTROSE<br/>							SOLUTIONS WITHOUT SALTS SHOULD<br/>NOT BE USED IN BLOOD TRANSFUSIONS <br/>							BECAUSE OF POSSIBLE ROULEAU<br/>FORMATION.</paragraph>
                  <paragraph>ADDITIVES MAY BE INCOMPATIBLE. <br/>CONSULT WITH PHARMACIST, IF<br/> AVAILABLE. WHEN INTRODUCING <br/>ADDITIVES, USE ASEPTIC<br/>TECHNIQUE, MIX THOROUGHLY AND<br/> DO NOT STORE.</paragraph>
                  <paragraph>SINGLE-DOSE CONTAINER. FOR<br/>INTRAVENOUS USE. USUAL DOSAGE:<br/>SEE INSERT. STERILE, NONPYROGENIC.<br/>USE ONLY IF SOLUTION IS CLEAR AND<br/>CONTAINER IS UNDAMAGED. MUST<br/>NOT BE USED IN SERIES CONNECTIONS.</paragraph>
                  <paragraph>Rx ONLY</paragraph>
                  <paragraph>
                     <content styleCode="bold">3<br/>v</content>
                     <br/>CONTAINS DEHP 						</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <paragraph>IM-4404<br/>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <renderMultiMedia referencedObject="MM5"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM5">
                     <text>PRINCIPAL DISPLAY PANEL - 20 g/100 mL Bag Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="fa7dd062-d44b-4264-8b7b-40cc3a00a963"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 20 g/100 mL Bag Overwrap</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">TO OPEN — TEAR AT NOTCH</content>
                  </paragraph>
                  <paragraph>The overwrap is a moisture and oxygen barrier. Do not remove<br/>unit from overwrap until ready for use. Visually inspect<br/>overwrap for tears or holes. Discard unit if overwrap is<br/>damaged. Use unit promptly when pouch is opened.<br/>Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room<br/>Temperature.] Protect from freezing. See insert. After removing<br/>the overwrap, check for minute leaks by squeezing container<br/>firmly. If leaks are found, discard solution as sterility may be<br/>impaired.</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>WR-0552</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM6"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM6">
                     <text>PRINCIPAL DISPLAY PANEL - 20 g/100 mL Bag Overwrap</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-06.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="cf61871b-160d-4b06-a048-b7ad6ae7d6c7"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 50 g/100 mL Bag Label</title>
               <text>
                  <paragraph>500 mL<br/>NDC 0990-7936-19</paragraph>
                  <paragraph>
                     <content styleCode="bold">DEXTROSE<br/>INJECTION,<br/>USP</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">50%</content>
                  </paragraph>
                  <paragraph>IN 1000 mL PARTIAL-FILL CONTAINER<br/>EACH 100 mL CONTAINS DEXTROSE, HYDROUS, USP<br/>50 g IN WATER FOR INJECTION.<br/>HYPERTONIC OSMOLARITY 2523 mOsmol/LITER (calc).<br/>pH 4.3 (3.2 to 6.5)<br/>SPECIFIC GRAVITY 1.170<br/>
                     <content styleCode="bold">CAUTION: HYPERTONIC. ADMINISTER ONLY AFTER<br/>DILUTION VIA CENTRAL VENOUS CATHETER.</content>
                     <br/>STERILE, NONPYROGENIC. SINGLE DOSE CONTAINER.<br/>
                     <content styleCode="bold">DOSAGE AND ADMINISTRATION:</content> SEE PACKAGE<br/>INSERT.<br/>CAUTION: DO NOT USE UNLESS SOLUTION IS <br/>CLEAR, CLOSURE IS INTACT, AND CONTAINER IS<br/>UNDAMAGED. CHECK FOR MINUTE LEAKS BY<br/>SQUEEZING FIRMLY. IF LEAKS ARE FOUND DISCARD<br/>CONTAINER AND CONTENTS AS STERILITY MAY<br/> BE IMPAIRED. MUST NOT BE USED IN SERIES<br/>CONNECTIONS.</paragraph>
                  <paragraph>ADDITIVES MAY BE INCOMPATIBLE. CONSULT<br/>WITH PHARMACIST, IF AVAILABLE. WHEN<br/>INTRODUCING ADDITIVES, USE ASEPTIC<br/>TECHNIQUE, MIX THOROUGHLY AND DO NOT<br/>STORE.</paragraph>
                  <paragraph>
                     <content styleCode="bold">RECOMMENDED STORAGE:</content> ROOM TEMPERATURE<br/>(25°C/77°F). AVOID EXCESSIVE HEAT. PROTECT FROM<br/>FREEZING.</paragraph>
                  <paragraph>Rx ONLY</paragraph>
                  <paragraph>IM-4433<br/>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">3<br/>v</content>
                     <br/>CONTAINS DEHP 						</paragraph>
                  <paragraph>
                     <content styleCode="bold">50%</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM7"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM7">
                     <text>PRINCIPAL DISPLAY PANEL - 50 g/100 mL Bag Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-07.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="32d8191e-11aa-44ce-84a6-366b584abe65"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 50 g/100 mL Bag Overwrap</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">TO OPEN — TEAR AT NOTCH</content>
                  </paragraph>
                  <paragraph>The overwrap is a moisture and oxygen barrier. Do not remove<br/>unit from overwrap until ready for use. Visually inspect<br/>overwrap for tears or holes. Discard unit if overwrap is<br/>damaged. Use unit promptly when pouch is opened. Store at<br/>20 to 25°C (68 to 77°F). [See USP Controlled Room<br/>Temperature.] Protect from freezing. See insert. After<br/>removing the overwrap, check for minute leaks by squeezing<br/>container firmly. If leaks are found, discard solution as sterility<br/>may be impaired.</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>WR-0555</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM8"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM8">
                     <text>PRINCIPAL DISPLAY PANEL - 50 g/100 mL Bag Overwrap</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-08.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="e084f3d1-b1b4-4c7e-8171-d0a929c3932d"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 40 g/100 mL Bag Label</title>
               <text>
                  <paragraph>500 mL<br/>IN 1000 mL PARTIAL-FILL CONTAINER</paragraph>
                  <paragraph>NDC 0990-7937-19</paragraph>
                  <paragraph>
                     <content styleCode="bold">40% DEXTROSE</content>
                     <br/>Injection, USP 						</paragraph>
                  <paragraph>EACH 100 mL CONTAINS DEXTROSE,<br/> HYDROUS 40 g IN WATER FOR INJECTION.<br/>2018 mOsmol/LITER (CALC.)<br/>pH 4.3 (3.2 to 6.5)<br/>
                     <content styleCode="bold">CAUTION: HYPERTONIC. ADMINISTER ONLY <br/>AFTER DILUTION VIA CENTRAL VENOUS<br/>CATHETER.</content> DEXTROSE SOLUTIONS<br/> WITHOUT SALTS SHOULD NOT BE USED<br/> IN BLOOD TRANSFUSIONS BECAUSE OF<br/> POSSIBLE ROULEAU FORMATION.</paragraph>
                  <paragraph>ADDITIVES MAY BE INCOMPATIBLE. <br/>CONSULT WITH PHARMACIST, IF<br/> AVAILABLE. WHEN INTRODUCING <br/>ADDITIVES, USE ASEPTIC TECHNIQUE, <br/>MIX THOROUGHLY AND DO NOT STORE.</paragraph>
                  <paragraph>SINGLE-DOSE CONTAINER. FOR<br/>INTRAVENOUS USE. USUAL DOSAGE: SEE<br/> INSERT. STERILE, NONPYROGENIC. USE<br/> ONLY IF SOLUTION IS CLEAR AND<br/>CONTAINER IS UNDAMAGED. MUST NOT<br/> BE USED IN SERIES CONNECTIONS.</paragraph>
                  <paragraph>Rx ONLY</paragraph>
                  <paragraph>
                     <content styleCode="bold">3<br/>v</content>
                     <br/>CONTAINS DEHP 						</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical</paragraph>
                  <paragraph>IM-4434<br/>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <renderMultiMedia referencedObject="MM9"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM9">
                     <text>PRINCIPAL DISPLAY PANEL - 40 g/100 mL Bag Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-09.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="c8fa77e8-92b9-4faf-ac92-b6e61362651f"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 40 g/100 mL Bag Overwrap</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">TO OPEN — TEAR AT NOTCH</content>
                  </paragraph>
                  <paragraph>The overwrap is a moisture and oxygen barrier. Do not remove<br/>unit from overwrap until ready for use. Visually inspect<br/>overwrap for tears or holes. Discard unit if overwrap is<br/>damaged. Use unit promptly when pouch is opened. Store at<br/>20 to 25°C (68 to 77°F). [See USP Controlled Room<br/>Temperature.] Protect from freezing. See insert. After removing<br/>the overwrap, check for minute leaks by squeezing container<br/>firmly. If leaks are found, discard solution as sterility may be<br/>impaired.</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>WR-0557</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM10"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM10">
                     <text>PRINCIPAL DISPLAY PANEL - 40 g/100 mL Bag Overwrap</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="c8fc8627-7d7b-4aa3-83e0-31592f81fb7d"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 30 g/100 mL Bag Label</title>
               <text>
                  <paragraph>500 mL<br/>IN 1000 mL PARTIAL-FILL CONTAINER</paragraph>
                  <paragraph>NDC 0990-8004-15</paragraph>
                  <paragraph>
                     <content styleCode="bold">30% DEXTROSE</content>
                     <br/>Injection, USP 						</paragraph>
                  <paragraph>EACH 100 mL CONTAINS DEXTROSE,<br/> HYDROUS 30 g IN WATER FOR INJECTION.<br/>1514 mOsmol/LITER (CALC.)<br/>pH 4.3 (3.2 to 6.5)<br/>
                     <content styleCode="bold">CAUTION: HYPERTONIC. ADMINISTER<br/> ONLY AFTER DILUTION VIA CENTRAL<br/> VENOUS CATHETER.</content> DEXTROSE<br/> SOLUTIONS  WITHOUT SALTS SHOULD<br/> NOT BE USED IN BLOOD TRANSFUSIONS<br/> BECAUSE OF POSSIBLE ROULEAU<br/> FORMATION.</paragraph>
                  <paragraph>ADDITIVES MAY BE INCOMPATIBLE. <br/>CONSULT WITH PHARMACIST, IF<br/> AVAILABLE. WHEN INTRODUCING <br/>ADDITIVES, USE ASEPTIC TECHNIQUE, <br/>MIX THOROUGHLY AND DO NOT<br/> STORE.</paragraph>
                  <paragraph>SINGLE-DOSE CONTAINER. FOR<br/>INTRAVENOUS USE. USUAL DOSAGE:<br/> SEE INSERT. STERILE, NONPYROGENIC.<br/> USE ONLY IF SOLUTION IS CLEAR AND<br/>CONTAINER IS UNDAMAGED. MUST<br/> NOT BE USED IN SERIES CONNECTIONS.</paragraph>
                  <paragraph>Rx ONLY</paragraph>
                  <paragraph>
                     <content styleCode="bold">3<br/>v</content>
                     <br/>CONTAINS DEHP 						</paragraph>
                  <paragraph>IM-4436<br/>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM11"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM11">
                     <text>PRINCIPAL DISPLAY PANEL - 30 g/100 mL Bag Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="138ba439-0b62-4b54-849a-14d17c04be66"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 30 g/100 mL Bag Overwrap</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">TO OPEN — TEAR AT NOTCH</content>
                  </paragraph>
                  <paragraph>The overwrap is a moisture and oxygen barrier. Do not remove<br/>unit from overwrap until ready for use. Visually inspect<br/>overwrap for tears or holes. Discard unit if overwrap is<br/>damaged. Use unit promptly when pouch is opened. Store at<br/>20 to 25°C (68 to 77°F). [See USP Controlled Room<br/>Temperature.] Protect from freezing. See insert. After removing<br/>the overwrap, check for minute leaks by squeezing container<br/>firmly. If leaks are found, discard solution as sterility may be<br/>impaired.</paragraph>
                  <paragraph>Rx only</paragraph>
                  <paragraph>WR-0560</paragraph>
                  <paragraph>ICU Medical, Inc., Lake Forest, Illinois, 60045, USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">icu</content>medical 						</paragraph>
                  <renderMultiMedia referencedObject="MM12"/>
               </text>
               <effectiveTime value="20181130"/>
               <component>
                  <observationMedia ID="MM12">
                     <text>PRINCIPAL DISPLAY PANEL - 30 g/100 mL Bag Overwrap</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-12.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>